RLAY
Relay Therapeutics, Inc.
18.36
1 x 13.18
1 x 18.21
bid
ask
+
0.60
3.35%
10:16 AM
timesize
| Ytd | 116.97% | |
| 1y | 409.87% |
17.68
day range
18.66
3.02
52 week range
19.93
| Open | 17.83 | Prev Close | 17.76 | Low | 17.68 | High | 18.66 | Mkt Cap | 4.01B |
| Vol | 317.21K | Avg Vol | 4.29M | EPS | -1.56 | P/E | N/A | Forward P/E | -11.33 |
| Beta | 1.75 | Short Ratio | 7.91 | Inst. Own | 86.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 14.59 | 200-d Avg | 9.88 | 1yr Est | 24.82 |
| Income Statement | |||
| Total Revenue | 3.00M | ||
| Revenues (USD) | 3.00M | ||
| Gross Profit | 3.00M | ||
| Operating Expenses | 81.59M | ||
| Research and Development Expense | 70.56M | ||
| Selling, General and Administrative Expense | 11.03M | ||
| Operating Income | -78.59M | ||
| Net Income | -73.29M | ||
| Net Income Common Stock | -73.29M | ||
| Net Income Common Stock (USD) | -73.29M | ||
| Consolidated Income | -73.29M | ||
| Earnings per Basic Share | -0.41 | ||
| Earnings per Basic Share (USD) | -0.41 | ||
| Earnings per Diluted Share | -0.41 | ||
| Earning Before Interest & Taxes (EBIT) | -73.29M | ||
| Earning Before Interest & Taxes (USD) | -73.29M | ||
| Weighted Average Shares | 179.85M | ||
| Weighted Average Shares Diluted | 179.85M | ||
| Balance Sheet | |||
| Cash and Equivalents | 205.93M | ||
| Cash and Equivalents (USD) | 205.93M | ||
| Investments | 437.48M | ||
| Investments Current | 437.48M | ||
| Current Assets | 658.46M | ||
| Property, Plant & Equipment Net | 39.82M | ||
| Total Assets | 699.61M | ||
| Debt Current | 3.89M | ||
| Total Debt | 31.57M | ||
| Current Liabilities | 29.75M | ||
| Debt Non-Current | 27.68M | ||
| Total Liabilities | 57.43M | ||
| Accumulated Retained Earnings (Deficit) | -2.09B | ||
| Accumulated Other Comprehensive Income | -172.00K | ||
| Shareholders Equity | 642.18M | ||
| Shareholders Equity (USD) | 642.18M | ||
| Assets Non-Current | 41.15M | ||
| Total Debt (USD) | 31.57M | ||
| Liabilities Non-Current | 27.68M | ||
| Trade and Non-Trade Payables | 4.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 504.00K | ||
| Net Cash Flow from Financing | 138.78M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 120.57M | ||
| Issuance (Purchase) of Equity Shares | 138.78M | ||
| Net Cash Flow from Investing | 32.90M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 32.90M | ||
| Net Cash Flow from Operations | -51.11M | ||
| Share Based Compensation | 10.54M | ||